One way New York State is considering streamlining its Medicaid costs is by expanding needle-exchange centers to help drug users prevent getting HIV and hepatitis C. But that may take federal funds, and Congress reinstated a ban on such funds last year.
A new Vancouver-based program, called Insite, has substantial benefits in terms of reduction in HIV infection and increased follow-up medical treatment of addicts.
Multiple news agencies reported that a trial vaccine reduced the risk of HIV infection by 30 percent. While I am encouraged by the results, we have yet to find a silver bullet.